ABS Capital Partners

Cariloop Secures $20 Million in Series C Funding to Accelerate Growth and Expand Caregiver Support Solutions

Retrieved on: 
Tuesday, April 9, 2024
Software, Managed Care, General Health, Professional Services, Family, Data Management, Consumer, Technology, Health Technology, Human Resources, Consulting, Health, ASPCA, Organization, KPMG, Growth, Entrepreneurship, Caregiver, Procter & Gamble, American Cancer Society, NPS, ABS Capital Partners, CAE, Investment, ABS, Traction, Workforce, Series, Insperity

Cariloop, the leading comprehensive caregiver support platform, today announced the successful closure of its Series C funding round, raising $20 million.

Key Points: 
  • Cariloop, the leading comprehensive caregiver support platform, today announced the successful closure of its Series C funding round, raising $20 million.
  • “The service we provide gives companies a way to support their working caregivers and drive employee wellbeing, productivity and retention.
  • As part of the Series C financing, Krusius will join Cariloop’s Board of Directors and Cal Wheaton, Partner at ABS Capital, will join as a Board Observer.
  • Steven Theesfeld, Cariloop’s Co-Founder, and Colin Patrick, Patterson Thoma Family Office’s Chief Investment Officer, will step down from the Board.

Liquidity Services Announces Retirement of Phillip A. Clough from its Board of Directors

Retrieved on: 
Friday, December 8, 2023
Family, Audit committee, Audit, Retirement, Liquidity Services, ABS Capital Partners, Management

Mr. Phillip A. Clough is retiring from the company’s board of directors, effective February 2, 2024, after 20 years of dedicated service, consistent with the company’s succession plan.

Key Points: 
  • Mr. Phillip A. Clough is retiring from the company’s board of directors, effective February 2, 2024, after 20 years of dedicated service, consistent with the company’s succession plan.
  • “Phil has been a trusted member of our Board for almost two decades.
  • We wish him and his family all the best following his retirement,” said Bill Angrick, Chairman and CEO.
  • The Board has also determined to make certain changes to the committee assignments of the independent directors effective February 2, 2024.

ABS Capital Closes First Continuation Fund

Retrieved on: 
Friday, October 13, 2023
Software, Finance, Health, Asset Management, Banking, Health Technology, Professional Services, Technology, Partnership, Health care, Human resource management, Kagawa Five Arrows, Software as a service, Arrows, ABS Capital Partners, Biotechnology, LP record, Growth, ABS, GP, Cryptocurrency, Institutum clericorum saecularium in communi viventium

The transaction supports the significant continued growth opportunity for both companies, providing additional time and capital for growth initiatives, while offering liquidity to existing limited partners.

Key Points: 
  • The transaction supports the significant continued growth opportunity for both companies, providing additional time and capital for growth initiatives, while offering liquidity to existing limited partners.
  • ABS fund investors were provided a choice to receive liquidity or continue their investment.
  • The transaction is capitalized by a consortium of new and existing ABS investors, who subscribed to a new partnership managed and controlled by ABS.
  • “The ABS Capital team is thrilled to partner with Kline Hill Partners and Five Arrows in supporting the continued growth of LabConnect and Viventium,” said ABS Managing Partner, Mike Avon.

GuidePoint Security Attracts New Round of Growth Capital

Retrieved on: 
Tuesday, October 10, 2023
Professional Services, Data Management, Security, Technology, Finance, Software, Guidepoint, Kirkland & Ellis, Fortune 500, Government, Piper, Organization, Risk, Partner, ABS Capital Partners, DLA Piper, Environment, Growth, Guggenheim Partners, Risk management

“As the complexity of the cybersecurity landscape becomes more pronounced -- with ever evolving threats, thousands of products, and continued resource challenges -- demand for our services and solutions has never been higher,” said Michael Volk, Chairman and CEO of GuidePoint Security. “We attribute this consistent and continued rapid growth to our steadfast commitment to partnering with our customers to solve their cybersecurity challenges. We’ve focused on hiring the best and brightest cybersecurity minds across the United States and investing in innovative service offerings to address new and emerging risks. Now with Audax Private Equity, we are set up to help even more customers across the U.S. and expand overseas.”

Key Points: 
  • GuidePoint Security , a cybersecurity solutions leader enabling organizations to make smarter decisions and minimize risk, today announced the closing of a funding round led by Audax Private Equity, a leading alternative investment manager and capital partner to middle market companies.
  • GuidePoint will leverage the investment to further accelerate growth across the United States and expand internationally.
  • “We attribute this consistent and continued rapid growth to our steadfast commitment to partnering with our customers to solve their cybersecurity challenges.
  • ABS Capital Partners, a prior investor in GuidePoint Security, participated in the transaction.

Transfr Closes $40M in Series C Growth Funding to Enable Career Mobility for Undiscovered Talent Through Its Virtual Reality Platform

Retrieved on: 
Thursday, September 28, 2023
Wearables, Mobile Technology, Business, IOT (Internet of Things), Audio, Video, Other Professional Services, Other Technology, Software, Human Resources, Hardware, Professional Services, Consumer Electronics, Technology, Mobile, Wireless, Other Education, Continuing, Apps, Applications, Training, Education, Workforce, Hospitality, Prison, Employment, Health care, JPMorgan Chase, Private Career Training Institutions Agency, VR, CTE, Student, Partner, Ernst & Young Entrepreneur of the Year Award, Series, Virtual reality, ABS Capital Partners, Growth, Tourism, Electricity, Nursing, Management, Aviation

Transfr , an emerging leader in virtual reality-based skills training for middle-skilled careers, announced a $40 million investment today.

Key Points: 
  • Transfr , an emerging leader in virtual reality-based skills training for middle-skilled careers, announced a $40 million investment today.
  • This round brings the total investment in Transfr to over $90 million since its founding in 2017.
  • The company developed an innovative VR-based platform, which hosts over 300 simulations that focus on careers that do not require a four-year degree.
  • If you are interested in bringing Transfr’s platform and services to your organization or community, please visit Transfr’s website or schedule a demo of the platform .

BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker

Retrieved on: 
Tuesday, September 19, 2023
Research, Nursing, Medical Devices, Medical Supplies, Hospitals, FDA, Biotechnology, Health, Science, Other Science, Weil, Concussion, CT, ABS Capital Partners, IDEC, Northwell Health, General partnership, Medicine, Brain, Biomarker, BrainScope Company, Inc., Weil, Gotshal & Manges, Aria, The Manges, MRI, Traction, Patient, AbbVie, Stanford University Medical Center, Machine learning, Rituximab, Artificial intelligence, Sport, Johns Hopkins, Trauma, ALS, Ibrutinib, Computer security, Medical imaging, Pharmaceutical industry, Biogen, Pharmacyclics

Brain diagnostics innovator BrainScope announced today a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s current Series B equity financing round.

Key Points: 
  • Brain diagnostics innovator BrainScope announced today a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s current Series B equity financing round.
  • This investment supports the ongoing development of a new Artificial Intelligence / Machine Learning derived brain-activity based biomarker to predict future onset of Alzheimer’s.
  • "The global market for Alzheimer’s disease treatments is expected to rise to over $13 billion by 2030.
  • BrainScope also announced the appointment of three prominent individuals to its Board of Directors: Michael A. Epstein, Richard A. Miller MD, and Ralph Terkowitz.

BrightTower Advises PowerReviews, Leading SaaS Provider of User-Generated Ratings and Reviews, in Sale to 1WorldSync

Retrieved on: 
Tuesday, August 22, 2023
Kroger, Software as a service, ABS Capital Partners, L'Oréal, Q&A, PowerReviews, Brand, Behind-the-scenes, Target, Organization, Walmart, Albertsons, PDP, Post Consumer Brands, UGC, Battery Ventures, Online shopping, Amazon

NEW YORK, Aug. 22, 2023 /PRNewswire/ -- 1WorldSync®, the Chicago-based technology company providing the world's leading brands and retailers with critical product information to help consumers make purchasing decisions, has acquired PowerReviews, a leading SaaS provider of user-generated ratings, reviews and other content.

Key Points: 
  • NEW YORK, Aug. 22, 2023 /PRNewswire/ -- 1WorldSync®, the Chicago-based technology company providing the world's leading brands and retailers with critical product information to help consumers make purchasing decisions, has acquired PowerReviews, a leading SaaS provider of user-generated ratings, reviews and other content.
  • BrightTower , a New York City headquartered investment banking and M&A advisory services firm, served as exclusive financial advisor to PowerReviews in this transaction.
  • Additionally, the solution delivers actionable insights to brands and retailers to drive more traffic, increase sales, and improve products and services.
  • "User-generated content, whether ratings and reviews, Q&A, images, or videos, are critical to the e-commerce shopping and buying experience.

RIBBIT Acquires ValidiFI®, Bolstering Data, Products and Market Presence

Retrieved on: 
Thursday, June 1, 2023
Data Management, Banking, Technology, Professional Services, Payments, Digital Cash Management, Digital Assets, Security, Data Analytics, Software, Fintech, Finance, ABS Capital Partners, Fraud, Acquisition, Comment, Cryptocurrency

RIBBIT, Inc ., the authority on alternative bank and payment data, today announces its acquisition of ValidiFI ®, a leading provider of fraud, compliance, and risk mitigation solutions.

Key Points: 
  • RIBBIT, Inc ., the authority on alternative bank and payment data, today announces its acquisition of ValidiFI ®, a leading provider of fraud, compliance, and risk mitigation solutions.
  • The acquisition will create the industry's leading banking and payment data solutions platform, improving the company’s product offering and creating the largest alternative database of bank and payment data in the marketplace.
  • RIBBIT’s predictive analytics and data assets combined with ValidiFI’s verification and compliance solutions will more than double an already strong market presence in addition to expanding the breadth and depth of products and services offered.
  • “I’m excited about the enormous opportunity to bring these two dynamic, industry-leading companies together,” says Greg Rable, CEO of RIBBIT.

EQS-News: Advanced Blockchain announces new project

Retrieved on: 
Tuesday, May 9, 2023
Talisman, IBC, NFT, EV, ETH, Dame Alice Owen's School, Fréchet inception distance, AB, XETRA, Decentralized finance, Research, Non-fungible token, Panopticon, Cornell University, Automation, ABS Capital Partners, ISIN, Krest-Khaldzhay, Fraunhofer, LINK, Centauri, MEV, Cryptocurrency, Polka dot

Mai 2023 - Advanced Blockchain AG (“AB”, Scale Frankfurt, primary market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator, architect and investor for the blockchain industry, announces its latest product innovation: AB Capital AI.

Key Points: 
  • Mai 2023 - Advanced Blockchain AG (“AB”, Scale Frankfurt, primary market Düsseldorf, XETRA: ISIN DE000A0M93V6), a leading incubator, architect and investor for the blockchain industry, announces its latest product innovation: AB Capital AI.
  • This revolutionary product is a data aggregator that employs state-of-the-art AI technology to deliver automated token selection and research.
  • peaq also integrated with Fetch.ai for AI-based process automation, and Fraunhofer-led AI project will store EV battery digital twins on peaq network.
  • The Panoptic team participated in the Cornell Blockchain conference and held a well-received public event where they showcased their product demo.

Scene Health Secures $17.7 Million Series B Financing Led by ABS Capital Partners

Retrieved on: 
Wednesday, April 12, 2023
Insurance, Other Health, Technology, Pharmaceutical, Practice Management, Managed Care, Professional Services, Mental Health, Hospitals, Clinical Trials, Science, Software, Other Science, Health, Research, Medicaid, ABS Capital Partners, Blue Wolf Capital Partners, Medicine, National Institutes of Health, Bangladesh Technical Education Board, CDC, CareFirst BlueCross BlueShield, Medicare, Mitch Kapor, Pharmacist, DOT, Patient, Tuberculosis, Nursing, Motivation, Mortality, Medication, NIH, Pharmaceutical industry, Scene

Scene Health , the leading medication engagement company, has closed an oversubscribed $17.7 million Series B growth financing led by ABS Capital Partners with participation from existing investors Claritas Health Ventures, as well as Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, PTX Capital, and Kapor Capital.

Key Points: 
  • Scene Health , the leading medication engagement company, has closed an oversubscribed $17.7 million Series B growth financing led by ABS Capital Partners with participation from existing investors Claritas Health Ventures, as well as Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, PTX Capital, and Kapor Capital.
  • Last week’s announcement of a $1.67 million National Institutes of Health (NIH) grant allowing Scene to provide medication adherence support to pediatric heart transplant recipients in Florida.
  • Series B funding proceeds will enable Scene to further accelerate its ability to serve Medicaid and Medicare managed care plans, pharmaceutical companies, and clinical research organizations.
  • This financing brings the total investment in Scene to over $25 million since its founding in 2014.